Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting.
John TazareRichard WyssJessica M FranklinLiam SmeethStephen J W EvansShirley V WangSebastian G SchneeweissIan J DouglasJoshua J GagneElizabeth J WilliamsonPublished in: Pharmacoepidemiology and drug safety (2022)
The data-adaptive approach of HDPS and the resulting benefits have led to its popularity as a method for confounder adjustment in pharmacoepidemiological studies. Reporting of HDPS analyses in practice may be improved by the considerations and tools proposed here to increase the transparency and reproducibility of study results.